Skip to content
2000
Volume 7, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

In vivo magnetic resonance spectroscopy is a powerful tool which can be applied non-invasively to monitor disease progression at a molecular level in the brain of human patients with Alzheimer's disease (AD) and transgenic mouse models of AD. Application of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) in transgenic mouse models of AD makes it possible to follow metabolic changes and structural changes at the same time longitudinally. This review focuses on in vivo MRS studies in transgenic mouse models of AD and highlights the future impact of MRS techniques in finding crucial biomarkers of AD.

Loading

Article metrics loading...

/content/journals/cmir/10.2174/157340511794653469
2011-02-01
2025-09-11
Loading full text...

Full text loading...

/content/journals/cmir/10.2174/157340511794653469
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test